Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial).
J Clin Psychiatry
; 73(3): e402-8, 2012 Mar.
Article
in En
| MEDLINE
| ID: mdl-22490266
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psychotherapy
/
Schizophrenia
/
Antipsychotic Agents
/
Cost-Benefit Analysis
/
Combined Modality Therapy
/
Dibenzothiazepines
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
J Clin Psychiatry
Year:
2012
Document type:
Article
Affiliation country:
Country of publication: